3D-printed sternum successfully implanted


Tuesday, 28 February, 2017

3D-printed sternum successfully implanted

A collaboration between CSIRO, Melbourne medical implant company Anatomics and British doctors has resulted in the world’s first implementation of a 3D-printed titanium and polymer sternum into a patient.

Designed by Anatomics and printed at CSIRO’s Lab 22 facility in Melbourne, the implant was custom made for 61-year-old Edward Evans, who had previously had his sternum removed due to a rare infection. While Evans recovered well from this initial surgery, the absence of a solid sternum meant that his heart and lungs were left extremely vulnerable.

Sternum implants are typically made from a hand-moulded cement block wedged in a synthetic mesh, but doctors have been searching for a better, more modern alternative. Evans’ surgeon found this alternative by contacting Anatomics, which is a world leader in the design and manufacture of bespoke surgical implants.

Anatomics designed a sternum featuring titanium — a strong, lightweight, biologically compatible metal that is not rejected in human bodies. The company’s designs were then sent to CSIRO, where they were fed into a 3D printer full of powdered titanium. The particles were fused together layer by layer by an electron beam until a sternum had been printed that would precisely fill the defect in Evans’ chest.

The printed sternum was returned to Anatomics for processing and cleaning and was coated in porous polyethylene — a substance manufactured to create a bone-like porous architecture and which also helps with tissue adhesion. Finally, the implant was sterilised and shipped to the UK for surgery.

The operation marked the first time a titanium sternum combined with a synthetic polymer has been used to replace bone, cartilage and tissue in a patient. Evans has since made a successful recovery, with motion capture tests finding that his breathing and chest movements have been corrected.

Sternum image courtesy of Niharb under CC BY-NC-ND 2.0

Related News

A pre-emptive approach to treating leukaemia relapse

The monitoring of measurable residual disease (MRD), medication and low-dose chemotherapy is...

Long COVID abnormalities appear to resolve over time

Researchers at UNSW's Kirby Institute have shown that biomarkers in long COVID patients have...

RNA-targeted therapy shows promise for childhood dementia

Scientists have shown that a new RNA-targeted therapy can halt the progression of a specific type...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd